Results 11 to 20 of about 88 (70)

Cyclization of the Analgesic α-Conotoxin Vc1.1 With a Non-Natural Linker: Effects on Structure, Stability, and Bioactivity. [PDF]

open access: yesJ Pept Sci
This study cyclized conotoxin Vc1.1 using polyethylene glycol (PEG) linkers of different lengths and demonstrates that linker length modulates the peptide's helicity, thereby influencing its biological activity and stability. ABSTRACT α‐Conotoxin Vc1.1 is a disulfide‐rich peptide and a promising drug candidate for treating neuropathic and chronic pain.
Zhang Y   +4 more
europepmc   +2 more sources

Computational Design of α-Conotoxins to Target Specific Nicotinic Acetylcholine Receptor Subtypes. [PDF]

open access: yesChemistry
FoldX was benchmarked as the best energy prediction method, and seven accurate molecular models of α‐conotoxin/nAChRs were developed as surrogates for the experimental complexes. The combined use of FoldX and these molecular models emerged as an effective approach to predict α‐conotoxins with improved pharmaceutical properties.
Wu X   +6 more
europepmc   +2 more sources

Cross Talk between α7 and α3β4 Nicotinic Receptors Prevents Their Desensitization in Human Chromaffin Cells. [PDF]

open access: yesJ Neurosci, 2022
Jiménez-Pompa A   +7 more
europepmc   +1 more source

Cysteine [2,4] Disulfide Bond as a New Modifiable Site of α-Conotoxin TxIB. [PDF]

open access: yesMar Drugs, 2021
Zhang B   +8 more
europepmc   +1 more source

Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors. [PDF]

open access: yesJ Med Chem, 2013
Luo S   +9 more
europepmc   +1 more source

Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists. [PDF]

open access: yesJ Neurochem, 2020
Hone AJ   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy